Dermal Fillers Market Size, Share, Industry, Forecast and outlook (2023-2030)

Dermal Fillers Market is segmented By Product Type (Absorbable Dermal Fillers, Non-Absorbable Dermal Fillers), By Material (Hyaluronic Acid (HA), Poly-L-Lactic Acid (PLA), Calcium Hydroxylapatite (CaH), Polymethylmethacrylate (PMMA), Collagen), By Application (Facial Line Correction Treatment, Lip Enhancement, Scar Treatment), By End-user (Hospitals, Ambulatory Surgical Centers, Dermatology Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030 

Dermal Fillers Market Report Overview

The Dermal Fillers Market report analyzes the global market size, shares, recent trends, competitive intelligence, and future market outlook. Dermal fillers are used in various cosmetic procedures to restore volume, smooth wrinkles, and enhance facial features. The market for dermal fillers is driven by increasing demand for aesthetic procedures and advancements in aesthetic medicine from America is growing. Key players in the Dermal Fillers Market include Allergan plc, Galderma S.A., Merz Pharma GmbH & Co. KGaA, and other prominent players operating in the market. 

Dermal Fillers Market Scope and Summary

To Download a free sample click here

Dermal fillers are injections that will plump up wrinkles and smooth lines on the face after taking it. Healthcare professionals generally inject dermal fillers in the areas near the eyes, mouth, and nose. This expected cosmetic procedure typically delivers results directly and lasts months or years.

Dermal Fillers Market Dynamics and Trends

The global dermal fillers market is driven by technological advancements, the growing adoption of dermal fillers in medical aesthetics surgeries, improving patient awareness, and rising expenditure on cosmetic procedures.

Increasing awareness of medical aesthetics procedures in the public drives market growth    

The rising demand for anti-aging and increasing social media awareness drive the market in the forecast period. As per the article published in the Aesthetic Surgery Journal in April 2022, technological advances and widespread use of social media have increased awareness of diverse standards of beauty and aesthetic outcomes, ultimately broadening definitions of beauty and attractiveness and the consciousness of treatment goals. This dramatic rise in customer spending on cosmetic procedures has, in turn, generated promising prospects for the aesthetic medicine market in the future.

Approximately 70% of surveyed physicians indicated that their patients should seek aesthetic treatments in their 20s and 30s. Among aesthetically conscious female survey respondents, 32% indicated that they should seek treatment in their 30s, and 37% reported that they should seek treatment in their 40s.

In addition, in the era of social media, the dermal fillers market has developed to include a younger demographic with facial re-balancing. These treatments, aimed at the enhancement and preservation of youth rather than correcting age-related changes, include chin augmentation, lip plumping, liquid rhinoplasty, and gummy smile modification.

Moreover, dermal fillers are deployed to increase the face to meet the aesthetic concept of beauty, dictating that certain curves, contours, dimensions, and ratios are fulfilled to have a conventionally attractive face or to reform volumetric dimensions and hence youth in the aging face. Facial regeneration using soft tissue biodegradable fillers, a non-permanent injectable device, provides an affordable and relatively safe procedure compared to permanent surgical cosmetic procedures.

The side effects of dermal fillers will hamper the growth of the market  

However, the side effects which tend to occur around the injection site can be immediate, including redness, swelling, pain, bruising, itching, and rash. Rare side effects include leakage of the filler through the injection site, granulomas, infection, inflammatory reaction to the filler, nodules around the injection site, movement of the filler from one area to another, and injury to blood vessels. These side effects limit the market growth.

COVID-19 Impact on Dermal Fillers Market Growth

The appearance of COVID-19 considerably impacted the global medical aesthetics market. As per the article published in September 2022, cosmetic procedures and esthetic interventions are some luxurious lifestyles rather than a necessity. There has been a substantial reduction in procedures performed at the beginning of the COVID pandemic.

However, social distancing has led people to spend long hours on video calls, which promoted appearance dissatisfaction and sometimes evolution of dysmorphic thoughts about the body, especially the face; this has resulted in increased demand for esthetic and cosmetic procedures.

On the other hand, the SARS-CoV-2 infection and associated vaccines have given rise to several dermatologic reactions in those individuals who have previously undergone cosmetic surgery or esthetic interventions. Moreover, the demand for improving physical and mental self-acceptance usually increases after any disaster or crisis, and COVID-19 is no exception.

As of 2022, the market is recovering from COVID-19, and almost all people can access healthcare and cosmetic facilities, which drives the market worldwide.

Dermal Fillers Market Segment and Shares

The Hyaluronic Acid (HA) segment is expected to grow at the fastest CAGR during the forecast period (2023-2030)        

The Hyaluronic Acid (HA) segment accounts for the largest market share. The popularity surge of injectable HA fillers has risen to in-vogue status. It has brought a concomitant gain in the incidence of once-rare iatrogenic vaso-occlusive injuries, from disfiguring facial skin necrosis to disabling neuro-ophthalmological sequelae.

As per the article published in Molecules 2022, dermal fillers have witnessed a surge in popularity in the two decades since HA injectable gels sales boomed by 700% between 2005 and 2020. As of 2022, the global market for cosmetic fillers registered a forecast of 65% by 2030.

 The advent of chemically cross-linked hyaluronic acid (HA, hyaluronan) gel derivatives has indicated a new era in the biomedical arena, yielding novel therapeutic applications in surgery and regenerative medicine, and pharmacology. However, it is perhaps the utilization of hydro colloidal HA-based dermal fillers in aesthetic medicine that has witnessed the most significant growth in the last years. The explosion in the use of these injectable HA gels has brought a simultaneous rise in the incidence of subtle ischemic tissue infarcts stemming from the accidental intravascular injection of gel boluses, resulting in filler-induced vascular occlusion.

Dermal Fillers Market Geographical Analysis

North America region holds the largest market share of the global dermal fillers market

North America dominates the market for dermal fillers and is anticipated to show a similar trend over the forecast period. The market is driven by factors such as advanced healthcare infrastructure. The increasing awareness of medical aesthetics procedures, active regional key players, and easy availability of products in the region.

As per the article published in Molecules 2022, in the United States alone, approximately 3.4 million dermal filler procedures are performed yearly, with HA fillers comprising nearly 80% of filler products. This increased demand for cosmetic injectables stems from the growing acceptance of plastic surgery procedures across all age and gender groups, increased accessibility and marketing, and decreased cost of products, creating an increasingly competitive market likely to favor further adoption.

In addition, the market players are adopting the market strategies such as collaboration and product launches to expand their business. For instance, in May 2020, AbbVie acquired Allergan to expand its business. Allergan has a portfolio of brands and best-class products mainly focused on four key therapeutic areas: medical aesthetics, eye care, central nervous system, and gastroenterology.

Dermal Fillers Companies and Competitive Landscape

The dermal fillers market is a moderately competitive presence of local and global companies. Some of the key players contributing to the market's growth are Allergan plc, Galderma, Merz Pharma, Sinclair Pharma plc, AQTIS Medical, Teoxane Laboratories, Cytophil Inc., Cynosure, Dr. Korman Laboratories Ltd., and Advanced Aesthetic Technologies Inc., among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, contributing to the growth of the dermal fillers market globally. 

For instance, 

• In January 2020, Anika Therapeutics, Inc., a global, integrated joint conservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid technology platform, agreed to acquire Parcus Medical, a leading, privately-held sports medicine company, and Arthrosurface, a leading, privately-held provider of the joint surface and preservation solutions for active patients.

Allergan plc

Overview:

Allergan (part of Abbevie) is an American pharmaceutical company founded in 2013, and it produces products through advanced research to develop next-generation neuromodulator therapies and other treatments for neurological conditions.

Product Portfolio:

JUVEDERM:  The JUVÉDERM family of hyaluronic acid dermal fillers corrects moderate to severe facial wrinkles and folds.

The global dermal fillers market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.